LVMH’s Thelios eyewear unit announced its acquisition of the high-end sunglasses brand, Vuarnet which is owned by French manufacturer Sporoptic Pouilloux S.A. but was bought by NEO Investment Partners in 2015. Thelios is now buying the iconic sunglasses label from the investment firm.
Vuarnet is the first-ever brand that Thelios has acquired, so it is thrilled to add it to its own portfolio. The company designs, makes, and supplies eyewear pieces to most of LVMH’s fashion houses, including Kenzo, Fendi, Dior, Loewe, Celine, and Stella McCartney. With Vuarnet now under its wing, Thelios is looking to augment its presence in the luxury eyewear market.
Thélios said that Vuarnet, which has more than 60 years of heritage and pioneering manufacturing of mineral lenses, would “perfectly” blend with its current portfolio as the brand is positioned at the crossroads of outdoors and fashion.
Fashion United UK reported that Vuarnet has over 60-year history of pioneering the production of mineral lenses. It is such an iconic name in the eyeglasses industry and Thelios is planning to “restore the brand's former glory."
The eyewear division of the LVMH Group also wants to scale up the product quality of Vuarnet’s products and develop it more beyond the boundaries of innovation. For its advancement, the French eyewear maker will use Thélios’ resources such as its research and development capabilities and technical expertise. It will also take advantage of Thelios’ global reach to push its own growth and expansion at the global level.
“We are thrilled to announce the acquisition of Vuarnet, becoming Thélios’ first proprietary brand,” Thelios’ chief executive officer, Alessandro Zanardo, said in a statement, “Vuarnet is a legendary brand, with a unique history that deserves to be preserved and perpetuated. Its iconic design, its unique know-how on mineral lenses and its strong brand values, are a perfect match with our ethos and positioning.”
Photo by: Annie Williams/Unsplash


Apple Turns 50: From Garage Startup to AI Crossroads
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Australia's Trade Surplus Surges in February on Gold Export Boom
Gold Prices Surge as U.S.-Iran Ceasefire Talks Spark Market Optimism
South Korea Manufacturing PMI Hits 4-Year High in March 2025 Driven by Semiconductor Demand
U.S. Stock Futures Steady Amid Iran Ceasefire Talks and Trump Address
RBI Clamps Down on Rupee NDF Activity, Banks Face Steeper Losses
Oil Prices Hold Near Multi-Year Highs Amid Iran Conflict and Hormuz Supply Fears
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Gold Prices Rebound in Asia Amid Iran War Ceasefire Hopes
Trump's Claim That the U.S. Can Cover Global Jet Fuel Shortfall Doesn't Add Up
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
U.S. Stocks Surge on Iran War De-escalation Hopes
Gold Prices Rebound But Head for Worst Month Since 2008 Amid Iran War Uncertainty
Trump's Iran War Speech Sparks Market Anxiety Over Extended Conflict
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 



